Navigation Links
Genstar Capital Launches New Senior Care Services Platform UniVita Health and Agrees to Acquire Outsourced Insurance Services Provider, Long Term Care Group
Date:12/1/2008

expected to be completed in December. Terms of the transaction were not disclosed.

About Long Term Care Group, Inc.

Long Term Care Group, Inc. (www.ltcg.com) is the country's largest long term care administrator, providing services to over 30 long term care insurers including nine of the top 10. The company offers comprehensive policy administration including application processing, premium billing, customer service and claims and care management. In addition, LTCG has a well respected consulting practice specializing in product development, risk management, compliance and actuarial services. Under its Nation's CareLink brand, LTCG provides a full range of both telephonic and face-to-face assessments utilizing its nationwide network of nurses. With almost 1,000 employees and over one million policies under management, LTCG is headquartered in Eden Prairie, Minnesota, and has operational centers in the Minneapolis, Nashville, Indianapolis and Orlando metropolitan areas.

About UniVita Health

UniVita Health will develop into an integrated senior care company that promotes independent aging through home-based care and support. Its mission is to help individuals maintain a life of peace-of-mind, dignity and independence as they age. UniVita is founded on the belief that a person's home should be maintained as the center of independent living for as long as possible. In addition to improving lives, UniVita will offer opportunities for consumers, businesses and payers to manage the costs associated with this home-based care. The organization will assist families and end-users with financial planning and financing if necessary. UniVita will also offer decision-support tools that help individuals and payors select quality and cost-effective care providers, products and services in the local community.

About Genstar Capital, LLC
'/>"/>

SOURCE Genstar Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Genstar Capital Promotes J. Ryan Clark to Principal
2. Genstar Capital Appoints Mark Hanson to Managing Director
3. China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details
4. Foundation Venture Capital Group Invests in Company Working to Protect Healthy Tissue During Cancer Treatment
5. Precision Therapeutics Secures $43 Million in Venture Capital Funding
6. Medipacs Chosen to Present at Invest Southwest Capital Conference
7. Capital BlueCross Receives Prestigious Corporation of the Year Award
8. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
9. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
10. SuperGen to Present at the Lazard Capital Markets Fifth Annual Healthcare Conference on November 18, 2008
11. VNUS Medical Technologies to Present at Lazard Capital Markets 5th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Reports On 2009 Annual General Meeting 2Helix BioPharma Reports On 2009 Annual General Meeting 3NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Undocumented Hispanics Face Health Care Roadblocks in U S 60405 1Undocumented Hispanics Face Health Care Roadblocks in U S 60405 2U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 1U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 2U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 3Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival 14666 1Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival 14666 2Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival 14666 3Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival 14666 4